RE: Motif2 Jul 2019 09:03
Latino
Your Quote:
“, but can’t stand back and not challenge certain posts that are simply misleading others, specially the greener PIs who might jump in thinking it’s so cheap without realising fundamentally this company in grave trouble.”
What “grave trouble “you are talking about! About raising funds obviously...I am not sure how long have been investing to say this company is in ‘grave trouble” simply because they are going to raise funds and try to get their new drug approved by the Fda like any other.
Every aim and other listed companies come to the market after raising funds...companies growing and expanding are raising funds...companies involve in M&A are raising funds. Where is the problem?!
Motif has done most of the good work so far and why raising funds should be an issue . The fda encouraged them to proceed with acquiring more data to make sure Iclaprim is safe by doing another trial..where is the issue in here!?
You do not know what you are talking about by calling others “giving misleading information”..what are the misleading information.....?? List them please.
You are free to write any negative but do not pick at others because they have a different views to yours or get preoccupied with your loss and bring others down with your negative thoughts constantly drivelling the same.
I can tell you again and again that I am positive on the progress of this sp and their product and my average is very low in comparison to others and very happy to hold . That is my opinion and my choice and my money. You had your chance here and lost but don’t obstruct others and let them hear everybody views ,all are adults and free to make choices. Be more flexible in your thinking ..
GL with your future investment.
Sign In
Follow the stocks
